Interview 3 Sep 2025
Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field.
- Latest Posts
In Depth 3 Sep 2025
How are biotechs tackling malaria?
As a recent approval closes a major therapeutic gap, let’s take a look at some of the latest progress and new treatments against malaria.
In Depth 2 Sep 2025
The biggest biotech funding rounds in August 2025
Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in August 2025.
In Depth 1 Sep 2025
Blood Cancer Awareness Month: What biotech holds in store
As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines.
Webinars 1 Sep 2025
Organoids in cancer research: Paving the way for faster drug development across cancer indications
Discover how patient-derived organoids enable smarter, quicker oncology drug development.
In Depth 29 Aug 2025
Can genetically modified crops help us adapt to climate change?
Find out whether genetically modified crops can help us adapt to climate change and ensure global food security.
ADVERTISEMENT
ADVERTISEMENT
Podcast 29 Aug 2025
A Finnish biotech is making progress on Parkinson’s disease with support from The Michael J. Fox Foundation
Our guest this week is Antti Vuolanto, CEO of Herantis Pharma, and we discussed the science behind their approach, and the advantages and challenges of working in biotech in the Nordics.
More News! 27 Aug 2025
Zemcelpro, the first blood cord expansion therapy to reach the EU market
Find out about ExCellThera’s zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally.
Best in Biotech 26 Aug 2025
Five biotech companies in South Korea you should know about
Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics areas.
Webinars 25 Aug 2025
Advancements in antimalarial drug discovery and development
Explore innovations in antimalarial drug discovery, from screening and compound design to resistance mechanisms and PK optimization.
In Depth 22 Aug 2025
The Sanofi pipeline in 2025: Is the play-to-win strategy working?
Find out what Sanofi has been up to in 2025, especially as it just closed the Opella deal and is now expanding its pipeline.
Podcast 22 Aug 2025
How RNAi is expanding from a therapy of choice for rare disease into treating common conditions
Our guest this week is Paul Nioi, Senior Vice President of Research at Alnylam and we talked about the evolution of RNAi.
ADVERTISEMENT
